Prakt. lékáren. 2011; 7(1): 34-38

Means of skin protection against harmful effects of UV radiation

PharmDr.Miroslav Miletín, Ph.D.
Univerzita Karlova v Praze, Farmaceutická fakulta Hradec Králové

Harmful effects of UV radiation on skin, especially for the fair one, are generally recognized fact, even if a small dose of the UV radiation

is necessary to run some important physiological processes. The main risk factor is an undisputable cancerogenic effect, however, there

are also unfavourable cosmetic impacts. In the case it is not possible to avoid the UV radiation exposition, or someone even wants to

sunbath, effective protection against the harmful of the UV radiation consequences employing UV filters (sunscreens) is highly desirable.

The scale of these means is quite wide, including several structural types of chemical organic filters and both organic and inorganic

pigments. However, not all of them are on the same level concerning the effectiveness, stability and lack of potential another impacts

on human body. This article affords an overview of the UV filters approved and used in EU (i. e. also in Czech Republic) and their most

important properties.

Keywords: UV radiation, skin protection, sunscreens

Published: February 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Miletín M. Means of skin protection against harmful effects of UV radiation. Praktické lékárenství. 2011;7(1):34-38.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Manniche L. Egyptian Luxuries: Fragrance, aromatherapy, and cosmetics in pharaonic times. Cairo: The American University in Cairo Press, 1999.
    2. Shaat M, Shaat N. Ancienit Egyptian cosmetics, toiletries and essentials oils. IFSCC 23rd Congress, paper 7, Orgando, Florida, 2004. Go to original source...
    3. Boulos L. Flora of Egypt. Vols. 1 and 2: Egypt. Al Hadra Publishing, 2000.
    4. Giacomoni PU. Sunprotection: historical perspektive. In: Shaath NA, ed. Sunscreens: regulations and commercial development. 3rd ed. New York: Marcel Dekker, 2005: 71-81.
    5. Dubreuilh W. Epitheliomatoses d´origine solaire. Ann. Dermatol. 1907; 8: 387.
    6. Unna PG. Die Histopatologie der Hautenkrankheiten. Berlin: Verlag von August Hirschwald, 1894.
    7. Patini G. Perfluoropolyethers in sunscreens. Drug Cosmet. Ind. 1988; 143: 42.
    8. Groves G. The sunscreen industry in Australia: past, present, and future. In: Lowe NJ, Shaath NA, Pathak MA, eds. Sunscreens: Development, evaluation, and regulatory aspects. 2nd ed., Chapter 12. New York: Marcel Dekker, 1997.
    9. http://www.szu.cz/Menu1/publikace/uv.pdf.
    10. Rameš J, Bencko O. Ultrafialové záření a jeho biologické účinky. Čas. Lék. Čes, 1993; 132: 129-133.
    11. Longstreth J. Cutaneous malignant melanoma and ultraviolet radiation: a review. Cancer Metastasis Rev. 1988; 7: 321-333. Go to original source... Go to PubMed...
    12. Woodhead AD, Setlow RB, Tanaka M. Environmental factors in nonmelanoma and melanoma skin cancer. J. Epidemiol. 1999; 9: 102-114. Go to original source... Go to PubMed...
    13. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L, et al. SEER Cancer Statistics Review, 2004; 1975-2001. http://seer.cancer.gov/csr/1975_2001.
    14. Baade P, Coory M. Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control. Aust. N. Z. J. Public Health 2005; 29: 383-386. Go to original source... Go to PubMed...
    15. IARC (1992). Vol. 55, Monograph on Solar and Ultraviolet Radiation, Vol. 52. International Agency for Research of Cancer, World Health Organisation, Lyon, France.
    16. Lund LP, Timmins GS. Melanoma, long wavelength ultraviolet and sunscreens: Controversies and potential resolutions. Pharmacology & Therapeutics 2007; 114: 198-207. Go to original source... Go to PubMed...
    17. Gorden A, Osman I, Gai W, He D, Huang W, Davidson A, et al. Analysis of BRAF and N-RAS mutations in metastatic melanoma tissues. Cancer Res. 2003; 63: 3955-3957.
    18. Pollock PM, Harper UL, Hansen KS, Yudt LM, Stark M, Robbins CM, et al. High frequency of BRAF mutations in nevi. Nat. Genet. 2003; 33: 19-20. Go to original source... Go to PubMed...
    19. Goldenberg-Cohen N, Cohen Y, Rosenbaum E, Herscovici Z, Chowers I, Weinberger D, et al. T1799A BRAF mutations in conjunctival melanocytic lesions. Invest. Ophthalmol. Visual. Sci. 2005; 46: 3027-3030. Go to original source... Go to PubMed...
    20. Edwards R, Ward M, Wu H, Medina C, Brose MPV, et al. Absence of BRAF mutations in UV protected mucosal melanomas. J. Med. Genet. 2004; 41: 270-272. Go to original source... Go to PubMed...
    21. Helmke BM, Mollenhauer J, Herold-Mende C, Benner A, Thome M, Gassler N, et al. BRAF mutations distinguish anorectal from cutaneous melanoma at the molecular level. Gastroenterology 2004; 127: 1815-1820. Go to original source... Go to PubMed...
    22. Wong C, Fan Y, Chan T, Chan A, Ho L, Ma T, et al. BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs. J. Clin. Pathol. 2005; 58: 640-644. Go to original source... Go to PubMed...
    23. Moan J, Dahlback A, Setlow RB. Epidemiological support for an hypothesis for melanoma induction indicating a role for UVA radiation. Photochem. Photobiol. 1999; 70: 243-247. Go to original source... Go to PubMed...
    24. Oliveria S, Dusza S, Berwick M. Issues in the epidemiology of melanoma. Expert. Rev. Anticancer. Ther. 2001; 1: 453-459. Go to original source... Go to PubMed...
    25. Wang S, Setlow R, Berwick M, Polsky D, Marghoob A, Kopf A, et al. Ultraviolet A and melanoma: a review. J. Am. Acad. Dermatol. 2001; 44: 837-846. Go to original source... Go to PubMed...
    26. Garland C, Garland F, Gorham E. Epidemiologic evidence for different roles of ultraviolet A and B radiation in melanoma mortality rates. Ann. Epidemiol. 2003; 13: 395-404. Go to original source... Go to PubMed...
    27. de Gruijl FR. Action spectrum for photocarcinogenesis. Recent Results Cancer Res. 1995; 139: 21-30. Go to original source... Go to PubMed...
    28. Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc. Natl. Acad. Sc. USA 2004; 101: 4954-4959. Go to original source... Go to PubMed...
    29. Green A, Battistutta D, Hart V. Skin cancer in a subtropical Asutralian population: Incidence and lack of association with occupation. Am. J. Epidemiol. 1998; 144: 1034-1040. Go to original source...
    30. Dennis L, Beane Freeman L, VanBeek M. Sunscreen use and the risk for melanoma: a quantitative review. Ann. Intern. Med. 2003; 139: 966-978. Go to original source... Go to PubMed...
    31. American Academy of Dermatology Public Resources. Solving problems related to the use of cosmetics in skin care products, September 28, 2003. American Academy of Dermatology, NetOn-line Services.
    32. Shaath NA. Evolution of modern sunscreen chemicals. In: Lowe NJ, Shaath NA, Pathak MA, eds. Sunscreens development, evaluation, and regulatory aspects. New York: Marcel Dekker, 1997: 3-33.
    33. Couteau C, Faure A, Fortin J, Paparis E, Coiffard LJM. Study of the photostability of 18 sunscreens in creams by measuring the SPF in vitro. J. Pharm. Biomed. Anal. 2007; 44: 270-273. Go to original source... Go to PubMed...
    34. Janjua NR, Morgensen B, Anderson AM, Petersen JH, Henriksen M, Skakebaek NE, Wulf HC. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J. Invest. Dermatol 2004; 123(1): 57-61. Go to original source... Go to PubMed...
    35. Hayden CGJ, Hoffmann N, Roberts MS, Benson HAE. A profile of the skin penetration of a common sunscreening agent: Oxybenzone. Perspect. Cut. Penetration 1997; 5B: 236-238.
    36. Jiang R, Roberts MS, Collins DM, Benson HAE. Skin penetration from sunscreens from commercial products. Perspect. Cut. Penetration 1997; 5B: 239-241.
    37. Jiang R, Roberts MS, Collins DM, Benson HAE. Absorption of sunscreens across human skin: An evaluation of commercial products for children and adults. Br. J. Clin. Pharmacol. 1999; 48(4): 635-637. Go to original source... Go to PubMed...
    38. Hayden CGJ, Roberts MS, Benson HAE. Systemic absorption of sunscreen after topical application. Lancet 1997; 350: 863-864. Go to original source... Go to PubMed...
    39. Benson HA. Assessment and clinical implications of absorption of sunscreens across skin. Am. J. Clin. Dermatol. 2000; 1(4): 217-224. Go to original source... Go to PubMed...
    40. Schlumpf M, Cotton B, Conscience M, Haller V, Steimann B, Lichtensteiger W. In vitro and in vivo estrogenicity of UV screens. Environ. Health. Perspect. 2001; 109(3), 239-244. Erratum in: Environ. Health. Perspect. 2001; 109(11): A517. Go to original source... Go to PubMed...
    41. Nařízení Evropského parlamentu a Rady (ES) č. 1223/2009 ze dne 30. listopadu 2009 o kosmetických přípravcích.
    42. Berset G, Gonzenbach H, Christ R, Martin R, Deflandre A, Mascotte RE, Jolley JDR, Lowell W, Pelzer R, Stihem T. Int. J. Cosmet. Sci. 1996; 18: 167-177. Go to original source... Go to PubMed...
    43. Sauermann G, Mann T, Wochnowski M. UV protection by sunscreens, P. Altmeyer, et al. (eds.), Skin Cancer and Radiation. Berlin-Heidelberg: Springer, 1997: 296-313. Go to original source...
    44. Diffey BL. Dosimetry of Ultraviolet radiation. In: Shaath NA, ed. Sunscreens: Regulations and Commercial Development. 3rd ed. New York: Marcel Dekker, 2005: 827-841.
    45. American Academy of Dermatology Public Resources. Solving problems related to the use of cosmetic in skin care products. September 28, 2003. American Academy of Dermatology. Produced by NetOn-line Services.
    46. Balfour JG. Back to basics, durability and titanium dioxide pigments. J. Oil Color Chem. Assoc. 1990; 78: 478.
    47. Innes B, Tsuzuki T, Dawkins H, Dunlop J, Trotter G, Nearn M, McCormick PG. Nanotechnology and cosmetic chemists. Technical bulletin, Advanced Nanotechnologies Pty. Ltd.
    48. Yoffe AD. Adv. Phys. 1993; 42: 173-266. Go to original source...
    49. Rules and regulations sunscreen drug products for overthe-counter human use. Final monograph, Federal register 1999; 64(98): 21.
    50. Pionnell SR, et al. Dermatol. Surg. 2000; 26(4): 39-314.
    51. Debute HV, et al. Dermatol. Clin. 2000; 18(4): 577-590. Go to original source... Go to PubMed...
    52. Kobayashi M, Kalriess W. Photocatalytic activity of titanium dioxide and zinc oxide. Cosmet. Toilet. 1997; 112: 83.
    53. Tsuzuki T. Photocatalytic behaviour of ZnO nanoparticle produced by mechanochemical processing. Technical Bulletin, Advanced Nanotechnologies Pty. Ltd.
    54. Lademann J, Weigmann HJ, Rickmeyer C, Barthelmes H, Schaefer H, Mueller G, Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the horny layer and the follicular orifice, Skin Pharmacol. Appl. Skin Physiol. 1999; 12: 247-256. Go to original source... Go to PubMed...
    55. Schulz J, Hohenberg H, Pflucker F, Gartner E, Will T, Pfeiffer S, Wepf R, Wendell V, Gersbarlag H, Wittern KP. Distribution of sunscreens on skin. Advanced Drug Delivery Reviews, 2002; 54(1). Go to original source... Go to PubMed...
    56. Gottbrath S, Müller-Goymann CC. Penetration and visualization of titanium dioxide microparticles in human stratum corneum, effect of different formulations on the penetration of titanium dioxide, SOFW J. 2003; 3(129): 11-17.
    57. Gamer AO, Leibold E, van Ravenzwaay B. The in vitro absorption of microfine zinc oxide and titanium dioxide through porcine skin, Toxicol. In Vitro 2005; 20: 301-307. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.